iBio, Inc. (IBIO): Total Assets
$99.11M
As of 2026-06-30
+34.0%
3-year compound annual growth
-7.6%
5-year compound annual growth
+6.7%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $99.11M | +327.5% | 2026-08-28, Balance as of period end |
| 2025-06-30 | $23.18M | -19.3% | 2026-08-28, Balance as of period end |
| 2024-06-30 | $28.73M | -30.3% | 2025-09-05, Balance as of period end |
| 2023-06-30 | $41.21M | -58.5% | 2024-09-24, Balance as of period end |
| 2022-06-30 | $99.41M | -32.4% | 2023-09-27, Balance as of period end |
| 2021-06-30 | $146.97M | +56.0% | 2022-10-11, Balance as of period end |
| 2020-06-30 | $94.19M | +207.9% | 2021-09-28, Balance as of period end |
| 2019-06-30 | $30.59M | -29.0% | 2020-10-13, Balance as of period end |
| 2018-06-30 | $43.08M | +19.6% | 2019-08-26, Balance as of period end |
| 2017-06-30 | $36.01M | -30.2% | 2018-09-18, Balance as of period end |
| 2016-06-30 | $51.60M | +313.0% | 2017-09-15, Balance as of period end |
| 2015-06-30 | $12.49M | +92.4% | 2016-10-13, Balance as of period end |
| 2014-06-30 | $6.49M | -30.6% | 2015-10-13, Balance as of period end |
| 2013-06-30 | $9.35M | -4.2% | 2014-09-29, Balance as of period end |
| 2012-06-30 | $9.77M | +33.1% | 2013-10-04, Balance as of period end |
| 2011-06-30 | $7.34M | n/a | 2012-10-15, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| iBio, Inc. (IBIO) | 2026-06-30 | $99.11M | +327.5% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $51.77M | -32.7% |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $2.81M | -49.4% |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $6.95M | +3.4% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $7.61M | +2.6% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $74.31M | -34.4% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $56.08M | -44.6% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $116.46M | -22.7% |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $17.74M | -49.3% |
Compare IBIO, ATNM, BFRG, SER side by side · Screen every company in Pharmaceutical Preparations ↗